Here's Why You Should Add Cencora Stock to Your Portfolio Now

Cencora's U.S. Healthcare Solutions strength, RCA gains, and raised FY25 guidance underscore its accelerating growth momentum.

Zacks Investment Research • Dec 10, 2025

Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year?

Here is how Cencora (COR) and CorMedix (CRMD) have performed compared to their sector so far this year.

Zacks Investment Research • Dec 9, 2025

Why Is Cencora (COR) Down 6.3% Since Last Earnings Report?

Cencora (COR) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Dec 5, 2025

Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global pharmaceutical solutions company, today announced investments to enhance its third-party logistics (3PL) capabilities in the United States and Europe, expanding its global network and strengthening the specialty logistics services it can deliver to pharmaceutical companies worldwide. As more specialty pharmaceuticals reach the market and the demand for comprehensive drug supply management continues to increase, Cencora is enhancing its globa.

Business Wire • Dec 3, 2025

Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript

Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript

Seeking Alpha • Dec 2, 2025

Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Seeking Alpha • Dec 2, 2025

Here's Why Cencora (COR) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Dec 2, 2025

Cencora (COR) Upgraded to Buy: Here's Why

Cencora (COR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research • Dec 2, 2025

Here's Why Cencora (COR) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Dec 1, 2025

Here's Why Cencora (COR) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Nov 25, 2025